PT3762009T - Construções de administração derivadas de toxinas para administração oral - Google Patents
Construções de administração derivadas de toxinas para administração oralInfo
- Publication number
- PT3762009T PT3762009T PT197170137T PT19717013T PT3762009T PT 3762009 T PT3762009 T PT 3762009T PT 197170137 T PT197170137 T PT 197170137T PT 19717013 T PT19717013 T PT 19717013T PT 3762009 T PT3762009 T PT 3762009T
- Authority
- PT
- Portugal
- Prior art keywords
- delivery
- toxin
- derived
- constructs
- oral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1077—Pentosyltransferases (2.4.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/02—Pentosyltransferases (2.4.2)
- C12Y204/02036—NAD(+)--diphthamide ADP-ribosyltransferase (2.4.2.36)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862640168P | 2018-03-08 | 2018-03-08 | |
| US201862640188P | 2018-03-08 | 2018-03-08 | |
| US201862640194P | 2018-03-08 | 2018-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3762009T true PT3762009T (pt) | 2022-08-22 |
Family
ID=66102749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT197170137T PT3762009T (pt) | 2018-03-08 | 2019-03-08 | Construções de administração derivadas de toxinas para administração oral |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU2019230230A1 (pt) |
| CA (1) | CA3093386A1 (pt) |
| PT (1) | PT3762009T (pt) |
| WO (1) | WO2019173787A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
| EP2616045B1 (en) | 2010-09-15 | 2017-10-25 | Randall J. Mrsny | Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
| SI3139965T1 (sl) | 2014-05-07 | 2022-01-31 | Applied Molecular Transport Inc. | Fuzijske molekule, izpeljane iz toksina cholix, za peroralno dostavljanje biološko aktivnega tovora |
| HUE059330T2 (hu) * | 2018-03-08 | 2022-11-28 | Applied Molecular Transport Inc | Toxinból származó bejuttatási konstrukciók orális beadásra |
| JP7516369B2 (ja) | 2018-11-07 | 2024-07-16 | アプライド モレキュラー トランスポート インコーポレイテッド | トランスサイトーシスのための送達構築物および関連する方法 |
| MX2021005382A (es) | 2018-11-07 | 2021-11-12 | Applied Molecular Transport Inc | Vehiculos derivados de cholix para suministro oral de carga util heterologa. |
| MX2022001975A (es) | 2019-08-16 | 2022-03-11 | Applied Molecular Transport Inc | Composiciones, formulaciones y produccion y purificacion de interleucinas. |
| WO2021155281A1 (en) * | 2020-01-31 | 2021-08-05 | Applied Molecular Transport Inc. | Compositions and methods for treatment of celiac disease |
| TW202245842A (zh) * | 2021-02-16 | 2022-12-01 | 美商應用分子運輸公司 | 具鋅之固體口服組合物 |
| WO2022240407A1 (en) * | 2021-05-12 | 2022-11-17 | Applied Molecular Transport Inc. | Delivery constructs derived from bacterial toxins and uses thereof |
| WO2022241167A1 (en) * | 2021-05-12 | 2022-11-17 | Applied Molecular Transport Inc. | Delivery constructs derived from bacterial toxins and uses thereof |
| WO2023141527A1 (en) * | 2022-01-21 | 2023-07-27 | Applied Molecular Transport Inc. | Furin-cleavable delivery constructs |
| WO2023196532A1 (en) * | 2022-04-08 | 2023-10-12 | Applied Molecular Transport Inc. | Chimeric il-10/carrier constructs for treatment of pouchitis and methods of use |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| FR2504010B1 (fr) | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| DE3377484D1 (en) | 1982-04-19 | 1988-09-01 | Nissan Motor | Method for controlling reduction ratio of continuously variable transmission with acceleration compensation |
| US5272065A (en) | 1983-10-20 | 1993-12-21 | Research Foundation Of State University Of New York | Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA |
| US4542225A (en) | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
| US4659839A (en) | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4680338A (en) | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| US4699784A (en) | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| US5807832A (en) | 1987-06-09 | 1998-09-15 | Biotech Australia Pty Limited | Oral delivery of biologically active substances bound to vitamin B12 |
| US5997856A (en) | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| US6613332B1 (en) | 1991-06-21 | 2003-09-02 | The University Of Cincinnati | Oral administration of therapeutic proteins |
| DK0590060T3 (da) | 1991-06-21 | 1998-05-11 | Univ Cincinnati | Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling |
| CN1163264C (zh) | 1993-02-02 | 2004-08-25 | 爱克索马技术有限公司 | 改进的药物组合物 |
| GB9320782D0 (en) | 1993-10-08 | 1993-12-01 | Univ Leeds Innovations Ltd | Stabilising of proteins on solution |
| GB9420355D0 (en) | 1994-10-10 | 1994-11-23 | Univ Nottingham | Preparation of protein microspheres, films and coatings |
| US5656730A (en) | 1995-04-07 | 1997-08-12 | Enzon, Inc. | Stabilized monomeric protein compositions |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| US5922680A (en) | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
| NZ335005A (en) | 1997-08-01 | 2000-12-22 | Toray Industries | Method for stabilizing cytokine using a compound arabic acid or the like |
| US6342611B1 (en) | 1997-10-10 | 2002-01-29 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof |
| US6592847B1 (en) | 1998-05-14 | 2003-07-15 | The General Hospital Corporation | Intramolecularly-quenched near infrared flourescent probes |
| BRPI0017437B8 (pt) | 1999-10-04 | 2021-05-25 | Chiron Corp | composição farmacêutica estabilizada contendo polipeptídeo il-2, método para aumentar estabilidade de interleucina-2 em uma composição farmacêutica, e uma forma seca da composição |
| US6673574B2 (en) | 2000-11-30 | 2004-01-06 | Unigene Laboratories Inc. | Oral delivery of peptides using enzyme-cleavable membrane translocators |
| US6573237B2 (en) | 2001-03-16 | 2003-06-03 | Eli Lilly And Company | Protein formulations |
| EP2616045B1 (en) * | 2010-09-15 | 2017-10-25 | Randall J. Mrsny | Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
| US8877161B2 (en) | 2011-10-19 | 2014-11-04 | Georgia Regents Research Institute, Inc. | GM1-like peptides and uses thereof |
| SI3139965T1 (sl) * | 2014-05-07 | 2022-01-31 | Applied Molecular Transport Inc. | Fuzijske molekule, izpeljane iz toksina cholix, za peroralno dostavljanje biološko aktivnega tovora |
-
2019
- 2019-03-08 CA CA3093386A patent/CA3093386A1/en active Pending
- 2019-03-08 AU AU2019230230A patent/AU2019230230A1/en active Pending
- 2019-03-08 PT PT197170137T patent/PT3762009T/pt unknown
- 2019-03-08 WO PCT/US2019/021474 patent/WO2019173787A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019173787A8 (en) | 2021-07-01 |
| AU2019230230A1 (en) | 2020-10-22 |
| CA3093386A1 (en) | 2019-09-12 |
| WO2019173787A1 (en) | 2019-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3762009T (pt) | Construções de administração derivadas de toxinas para administração oral | |
| CA195361S (en) | Toothbrush | |
| IL275989B (en) | Encapsulated cannabinoid formulations for oral delivery | |
| GB2559774B (en) | Oral cannabinoid formulations | |
| CA187655S (en) | Toothbrush | |
| PL3541357T3 (pl) | Doustne podłoże dostarczające | |
| IL277209A (en) | Structures for administration of toxin derivatives for oral administration | |
| IL278801A (en) | A device for administering aspiration of radioactive materials | |
| HUE061465T2 (hu) | Tisztítóhüvely a szájüreg tisztításához | |
| ZA202101506B (en) | Single blister-strip based dispenser | |
| GB201804165D0 (en) | Urethal delivery device | |
| GB201807040D0 (en) | Drug delivery | |
| CA187183S (en) | Oral irrigator | |
| CA187143S (en) | Oral irrigator | |
| PL3793609T3 (pl) | Preparat w postaci doustnego roztworu | |
| ZA201704594B (en) | Oral delivery product | |
| KR102097432B9 (ko) | 일회용 정량 스포이트 | |
| GB2572137B (en) | Delivery apparatus | |
| CA187560S (en) | Toothbrush | |
| CA186940S (en) | Toothbrush | |
| CA186941S (en) | Toothbrush | |
| EP3672446C0 (de) | Interdentalbürste | |
| GB201913609D0 (en) | Oral Delivery System | |
| GB201913606D0 (en) | Oral Delivery System | |
| CA187171S (en) | Lingual tube |